Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction.

ABSTRACT: Injectable biopolymer hydrogels have gained attention for use as scaffolds to promote cardiac function and prevent negative left ventricular (LV) remodeling post-myocardial infarction (MI). However, most hydrogels tested in preclinical studies are not candidates for minimally invasive catheter delivery due to excess material viscosity, rapid gelation times, and/or concerns regarding hemocompatibility and potential for embolism. We describe a platform technology for progelator materials formulated as sterically constrained cyclic peptides which flow freely for low resistance injection, and rapidly assemble into hydrogels when linearized by disease-associated enzymes. Their utility in vivo is demonstrated by their ability to flow through a syringe and gel at the site of MI in rat models. Add

SUBMITTER: Carlini AS 

PROVIDER: S-EPMC6465301 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature